3WuY Kudsk KA, De Witt RC et al. Route and type of nutrition influence IgA - mediating intestinal cytokines. Ann Surg, 1999,229 ( 5 ): 662～667.
4Takagi K, Yamamori H, Morishima Y, et al. Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy. Nutrition,2001,17 ( 1 ): 13～17.
5Fukatsu K, Lundberg AH, Kudak KA, et al. Modulation of organ ICAM -1 expression during Ⅳ - TPN with glutamine and bombesin. Shock,2001,15(1) :24～28.
6Alscher KT, Phang PT, McDonald TE, et al. Enteral feeding decreases gut apoptosis, permeability and lung inflammation Liver Physiol, 2001,281 (2) :G569～76.
7Manhart N, Vierlinger K, Spitter A, et al. Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann Surg,2001,234( 1 ) :92～97.
8Takagi K, Yamamori H, Toyoda Y, et al. Modulating effects of the feeding route on stress response and endotoxin translocation in severely stressed ptaients receiving thoracic esophagectomy. Nutrition,2000,16 (5) :355～360.
9Hawkcr FH How to feed patients with sepsis. Curr Opin Crit Care ,2000,6(4) :247～252.
二级参考文献8
1[1]Milner JA, Stepanovich LV. Inhibitory effect of dietary arginine on growth of Ehrlich ascites tumor cells in mice. J Nutr ,1979 , 109(3):489～494.
2[2]Sheng-long Ye, MD, MS, et al. Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. Cancer ,1992,69:261～270.
3[3]Edwards PD, Topping D, Kontaridis MI,et al. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. JPEN J Parenter Enteral Nutr, 1997,21(4):215～219.
4[4]Park KGM, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietartary L-arginine.Clin Sci,1992, 82: 413.
5[5]Terrault NA, Zhou S, McCory RW, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, 1998, 28(2): 555.
6[6]Grossie VB Jr,Nishioka K. Effect of ornithine in parenteral nutrition regimens on difluoromethy-lornithine-induced platelet suppression and changes in tumor polyamine content. Cancer Invest,1998,16(3): 160.
7[7]Grossie VB Jr, Nishioka K, Ajani JA, et al. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth. J Surg Oncol 1992,50(3):161.
8J. L. Rombeau,J. Takala. Summary of round table conference: gut dysfunction in critical illness[J] 1997,Intensive Care Medicine(4):476～479
